← Browse by Condition
Medical Condition
limited stage small cell lung cancer ls sclc
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgi...
Sponsor
Shanghai Junshi Bioscience Co....
NCT06869239
Recruiting
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Enrollment
65 pts
Location
China
Sponsor
Peking University Cancer Hospi...